Skip to navigation bar Skip to breadcrumbs Skip to page content
clear place holder Browse All Topics Envelope icon E-mail Updates Teal square Text size:  a A A

cobweb icon Archived: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication

Original Release Date: March 2007

This version of this topic is currently archived and inactive. It should be used for historical purposes only.

Archived: Recommendation Summary

Summary of Recommendation

(What's This?)

The USPSTF recommends against the routine use of aspirin and nonsteroidal anit-inflammatory drugs (NSAIDS) to prevent colorectal cancer in individuals at average risk for colorectal cancer. 

The USPSTF recommends against the service. There is moderate or high certainty that the service has no net benefit or that the harms outweigh the benefits

Archived: Related Information for Consumers

There is no related information for consumers.

Archived: Clinical Summary

Clinical summaries are one-page documents that provide guidance to primary care clinicians for using recommendations in practice.

There is no Clinical Summary for this recommendation.

Current as of: July 2015

Internet Citation: Final Update Summary: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication. U.S. Preventive Services Task Force. July 2015.

USPSTF Program Office   5600 Fishers Lane, Mail Stop 06E53A, Rockville, MD 20857